查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1807575

全球乳房切片设备市场按产品、程序类型、技术、类别、应用、最终用户和分销管道分類的预测（2025 年至 2030 年）

Breast Biopsy Device Market by Product, Procedure Type, Technique, Category, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年全球乳房切片设备市场规模将达到 22.8 亿美元，2025 年将成长至 24.2 亿美元，2030 年将达到 33.2 亿美元，复合年增长率为 6.43%。

主要市场统计数据
基准年：2024年 22.8亿美元
预计年份：2025年 24.2亿美元
预测年份：2030年 33.2亿美元
复合年增长率（%） 6.43%

过去十年，影像技术及程序的进步从根本上改变了乳房病变的诊断方法。如今，临床医生将高解析度视觉化技术与微创取样技术结合，以优化诊断准确性，减轻患者不适，并简化治疗方案。早期检测策略不再局限于标准的乳房X光摄影。断层合成、超音波和磁振造影引导的整合，开启了标靶干预的新时代，从而改善了病变定位和组织特征的描述。

同时，设备製造商也扩展了其产品组合，涵盖了各种各样的产品，包括切片穿刺针、引导系统以及辅助产品，例如用于支援复杂手术的定位导丝和定位台。从纯手动设备到自动化系统的转变，凸显了临床环境中工作流程效率和可重复性的普遍趋势。随着对患者安全的日益关注，产品设计也优先考虑人体工学、即时回馈以及与数位成像网路的兼容性。

本执行摘要概述了塑造乳房切片设备领域的关键趋势。它概述了变革性的技术变革，评估了监管和竞争动态的影响，探索了特定领域的洞察，评估了区域和竞争格局，并提出了策略建议。其目标是帮助决策者准确理解该行业的发展轨迹，并突出创新和投资将带来最大临床和商业性效益的可行领域。

乳房切片技术的重大模式转移和临床实践的演变将重新定义患者结果的效率和准确性

临床医生和行业领袖都在经历乳房切片程序规划和执行方式的模式转移。超音波和断层合成引导的广泛应用减少了对立体定位平台的依赖，使无法触及的病灶能够更精确地定位，并提高了诊断率。同时，磁振导航的手术已成为高风险患者的必需，它能够提供无与伦比的软组织造影，并能够可靠地探查深部和后部病变。

评估近期美国关税对切片检查设备製造商的供应链成本结构和竞争动态的更广泛影响

美国当局将于2025年对进口医疗设备零件征收新关税，这将为切片检查器械製造商和医疗保健提供者带来全新而复杂的局面。依赖特种合金和微机械引导零件的供应商正面临投入成本上升的压力，这促使他们重新评估全球筹资策略。这促使一些器械製造商加快转向国内生产，或在贸易友善地区寻找替代零件供应商。

透过对产品、流程类型、技术、类别、应用、最终用户和分销管道细分进行深入全面的分析，提供策略见解

按产品套件细分评估，涵盖了用于生物标记分析的客製化检测试剂盒、一系列针对组织采集优化的活检切片穿刺针、便于患者定位的客製化手术台、集成显像模式的先进导航系统，以及用于精准标记病变的精密定位导丝等产品，从而能够更好地了解设备性能和用户需求。每个产品类型都对应诊断工作流程中的不同阶段，凸显了整个流程生态系统中相容性和互通性的重要性。

区域视角突显美洲、欧洲、中东和非洲以及亚太地区独特的需求驱动因素、机会和挑战

美洲地区的动态反映了其全面的医疗保健基础设施，报销框架和大规模筛检计画正在推动影像引导切片检查解决方案的快速应用。由于手术量大且医生偏好微创治疗，美国在自动化真空辅助和先进引导系统的应用方面处于领先地位。同时，拉丁美洲市场虽然对价格敏感，但随着就地检验计画的推进，对可携式超音波引导设备的需求正在增长。

领先仪器製造商的策略概况和创新蓝图推动乳房切片领域的竞争优势

乳房切片设备领域的主要参与企业正在利用研发方面的策略性投资，推出下一代采样工具和数位化工作流程增强功能。拥有全面诊断产品组合的资深企业集团正在将切片检查平台与云端影像管理系统结合，以实现无缝资料交换和远距离诊断支援。与这些功能丰富的产品系列形成鲜明对比的是专注于利基应用的专业设备创新者，例如兼容MRI的切片穿刺针和快速现场评估套件。

为製造商、医疗保健提供者和投资者提供策略建议，以抓住乳房切片领域的商机并降低风险

寻求增强自身影响力的製造商应优先开发集影像引导、自动化和数位报告功能于一体的整合平台。透过将产品蓝图与临床医生工作流程和电子健康记录系统结合，企业可以降低采用门槛，并在手术效率和诊断准确性方面展现出显着的价值。同时投资培训计画和基于模拟的教育，可以进一步促进使用者熟悉，并建立更牢固的客户关係。

综合多方法研究途径，整合主要质性访谈、二级资讯来源和严格的三角测量过程

本研究采用多方法研究，结合了顶尖乳房摄影专家、介入放射科医师和肿瘤外科医师的深入定性访谈。为了确保临床和科学的严谨性，本研究还全面查阅了同行评审期刊、监管文件和专业协会指南，从而补充了这些关键见解。研究者对多个资讯来源的资料点进行了三角测量，以检验手术趋势、设备采用率和区域部署模式。

整合重点洞察，重点在于创新采用、市场变化、监管发展以及相关人员的策略要务

在先进影像处理、自动化取样和数位分析工具整合的推动下，乳房切片设备领域正以惊人的速度发展。向微创手术的转变正在提高诊断信心，同时减轻患者负担。同时，全球贸易动态和关税结构迫使相关人员重新思考其供应链策略和区域伙伴关係。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 扩大人工智慧影像导引在真空辅助乳房切片设备的应用
  • 扩展超音波引导下芯针活检解决方案，用于乳房即时诊断
  • 对 3D 成像整合微创立体定向切片检查系统的需求不断增长
  • 切片穿刺针设计的进步提高了患者的舒适度并缩短了手术时间
  • 整合数位病理学平台，即时分析乳房切片样本
  • 新兴市场对可携式乳房切片设备的采用激增，以提高其可及性
  • 3D立体定位切片检查系统结合机器人精确度和低辐射暴露
  • 符合人体工学优化的切片穿刺针可减少患者的不适并缩短手术时间
  • 移动乳房切片装置促进医疗资源匮乏地区的早期发现

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章乳房切片设备市场（按产品）

  • 检测试剂套件
  • 切片穿刺针
  • 切片检查
  • 导引系统
  • 本地化线路

第九章乳房切片设备市场（依手术类型）

  • 芯针切片
  • 细针穿刺法
  • 真空辅助切片检查

第 10 章乳房切片设备市场（按技术）

  • MRI 指南
  • 立体定位放射治疗
  • 断层合成指南
  • 超音波引导

第 11 章乳房切片设备市场（按类别）

  • 自动切片检查装置
  • 手动切片检查装置

第 12 章乳房切片设备市场（依应用）

  • 良性病变的诊断
  • 恶性病变的诊断

第 13 章乳房切片设备市场（依最终用户）

  • 门诊手术中心
  • 诊断影像中心
  • 医院

第 14 章乳房切片设备市场（依分销管道）

  • 线下销售
  • 网上销售

15.美洲乳房切片切片设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16. 欧洲、中东和非洲乳房切片设备市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

17. 亚太乳房切片设备市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十八章竞争格局

  • 市场占有率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争分析
    • Advin Health Care
    • Argon Medical Devices, Inc.
    • Becton, Dickinson and Company
    • Cook Group Incorporated
    • Danaher Corporation
    • FUJIFILM Corporation
    • General Electric Company
    • Halma plc
    • Hologic, Inc
    • INRAD Inc.
    • Medline Industries, LP
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Ningbo Xinwell Medical Technology Co., LTD.
    • PAJUNK GmbH
    • Planmeca Oy
    • Point Blank Medical
    • Siemens AG
    • SNVL Varay Laborix
    • STERYLAB Srl
    • Suretech Medical Inc.
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Vector Medical, Inc.
    • Zamar Care

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

Product Code: MRR-807A20B5CD96

The Breast Biopsy Device Market was valued at USD 2.28 billion in 2024 and is projected to grow to USD 2.42 billion in 2025, with a CAGR of 6.43%, reaching USD 3.32 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.28 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 6.43%

Over the past decade, advancements in imaging modalities and procedural techniques have fundamentally altered the approach to diagnosing breast lesions. Clinicians now combine high-resolution visualization with minimally invasive sampling to optimize diagnostic precision, reducing patient discomfort and streamlining care pathways. Early detection strategies are no longer confined to standard mammography; the integration of tomosynthesis, ultrasound, and magnetic resonance guidance has ushered in a new era of targeted interventions that improve lesion localization and tissue characterization.

In parallel, device manufacturers have expanded their portfolios to include a diverse array of biopsy needles, guidance systems, and ancillary products such as localization wires and tables that support complex procedures. The transition from purely manual devices to automated systems underscores a broader trend toward workflow efficiency and reproducibility in clinical settings. With an increased focus on patient safety, product designs now prioritize ergonomics, real-time feedback, and compatibility with digital imaging networks.

This executive summary synthesizes the critical trends shaping the breast biopsy device domain. It outlines transformative technological shifts, assesses the impact of regulatory and trade dynamics, examines segment-specific insights, evaluates regional and competitive landscapes, and presents strategic recommendations. The goal is to equip decision-makers with a nuanced understanding of the industry's trajectory and to highlight actionable areas where innovation and investment can yield the greatest clinical and commercial returns.

Key Paradigm Shifts in Breast Biopsy Technologies and Evolving Clinical Practices Redefining Patient Outcomes Efficiency and Precision

Clinicians and industry leaders alike are witnessing a paradigm shift in how breast biopsy procedures are planned and executed. The widespread adoption of ultrasonography and tomosynthesis guidance has reduced reliance on stereotactic platforms, enabling more precise targeting of non-palpable lesions and augmenting diagnostic yield. Concurrently, magnetic resonance guided techniques have become indispensable for high-risk patients, offering unparalleled soft-tissue contrast and the ability to access deep or posterior lesions with confidence.

Beyond imaging, the transition from core needle and fine needle aspiration to vacuum assisted biopsy systems reflects an emphasis on obtaining larger tissue volumes while minimizing sampling error. This shift has been accompanied by the development of next-generation biopsy needles that leverage advanced tip geometries and hydrophilic coatings to reduce insertion force and improve specimen integrity. These enhancements have translated into fewer needle passes, shorter procedure times, and a lower incidence of patient discomfort.

Artificial intelligence and artificial vision technologies are now being integrated into guidance platforms to assist with lesion segmentation and needle path planning. Such digital augmentation not only accelerates decision-making in the procedure room but also supports telemedicine applications, enabling remote expert consultation in real time. As a result, service providers are redefining care models to deliver faster turnarounds and more personalized diagnostic experiences, heralding a new chapter in precision breast health management.

Evaluating the Broad Effects of Recent United States Tariffs on the Supply Chain Cost Structures and Competitive Dynamics of Biopsy Device Manufacturers

The imposition of new tariffs on imported medical device components by United States authorities in 2025 has introduced a fresh layer of complexity for biopsy device manufacturers and healthcare providers. Suppliers reliant on specialized alloys and microfabricated guidance parts have experienced upward pressure on input costs, prompting a reevaluation of global sourcing strategies. In response, some device makers have accelerated their shift toward domestic production or have sought alternative component suppliers in trade-friendly regions.

Pricing adjustments have rippled through procurement budgets at ambulatory surgery centers, diagnostic imaging centers, and hospital systems, leading to more vigorous price negotiations and, in certain instances, the delayed adoption of premium biopsy tables and guidance systems. Simultaneously, manufacturers with in-house vertical integration have demonstrated greater resilience, securing operational continuity while maintaining tighter control over cost structures. These firms have been better positioned to weather the tariff-induced disruptions and to preserve customer relationships through value-added service agreements.

Looking ahead, the threat of additional trade measures has underscored the importance of cross-border regulatory alignment and the cultivation of dual-sourcing networks. Strategic partnerships between device innovators and regional contract manufacturing organizations have gained momentum as a means to safeguard supply chain robustness. Ultimately, the 2025 tariff landscape has reinforced the critical interplay between geopolitical factors and clinical technology deployment, shaping the competitive dynamics of the biopsy device domain.

In-Depth Comprehensive Analysis of Product Procedure Type Technique Category Application and End User Segments for Targeted Strategic Insights

A nuanced understanding of device performance and user requirements emerges when assessments are segmented by product type, encompassing offerings such as assay kits tailored for biomarker analysis, a range of biopsy needles optimized for tissue capture, customizable procedure tables that facilitate patient positioning, advanced guidance systems that integrate imaging modalities, and precision localization wires designed for accurate lesion marking. Each product category addresses a distinct phase of the diagnostic workflow, underscoring the importance of compatibility and interoperability across the procedural ecosystem.

Procedural segmentation reveals that core needle biopsy remains a mainstay for sampling both palpable and non-palpable masses, while fine needle aspiration continues to serve in cytology-driven contexts where minimal tissue disruption is paramount. Vacuum assisted biopsy has gained traction among clinicians seeking larger specimens and lower repeat rates, with automated devices offering consistent sampling profiles that reduce user dependency.

Technique-based differentiation highlights the growing prevalence of MRI guided interventions in high-complexity cases, juxtaposed with the ubiquity of ultrasound guided methods in routine screenings and diagnostic follow-ups. Tomosynthesis guided biopsies have emerged as a hybrid approach, delivering three-dimensional lesion visualization with lower radiation exposure than traditional stereotactic guidance.

From a device category perspective, automated systems are increasingly favored for their reproducibility and workflow integration, while manual devices retain their appeal in resource-constrained settings and mobile screening units. Applications span the spectrum from benign lesion diagnosis, where rapid turnover and cost-effectiveness are prioritized, to malignant lesion diagnosis, which demands the highest levels of sampling accuracy and tissue integrity. End user considerations further differentiate demand across ambulatory surgery centers known for efficiency, diagnostic imaging centers valued for specialized expertise, and hospitals that accommodate complex case mixes. Finally, distribution channels bifurcate into offline sales, driven by established procurement processes, and online sales, which have gained momentum through digital catalogues and e-commerce portals.

Regional Outlook Revealing Unique Demand Drivers Opportunities and Challenges Across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics in the Americas reflect a consolidated healthcare infrastructure, where reimbursement frameworks and large-scale screening programs have catalyzed the rapid uptake of image-guided biopsy solutions. The United States leads in the adoption of automated vacuum assisted and advanced guidance systems, driven by high procedure volumes and strong physician preferences for minimally invasive approaches. Meanwhile, Latin American markets, though more price-sensitive, are showing growing demand for portable ultrasound guided devices that align with point-of-care testing initiatives.

In Europe, Middle East and Africa, heterogeneity in healthcare funding and regulatory pathways influences the diffusion of new technologies. Western Europe's mature reimbursement environment supports the integration of tomosynthesis and MRI guided platforms, whereas parts of the Middle East are investing heavily in cutting-edge facilities to serve medical tourism sectors. African regions with limited infrastructure tend to adopt manual and cost-effective biopsy needles, although pilot programs in tertiary centers are testing more sophisticated guidance equipment.

The Asia Pacific region is characterized by dynamic growth, propelled by rising breast cancer awareness and expanding public healthcare expenditure. Emerging economies are prioritizing the deployment of ultrasound guided systems in community hospitals, while advanced markets in Japan and Australia emphasize precision imaging and the standardization of biopsy protocols. Local manufacturing initiatives and government-sponsored screening drives are shaping regional procurement strategies, underscoring the importance of scalable solutions that align with diverse clinical and economic environments.

Strategic Profiles and Innovation Roadmaps of Leading Device Manufacturers Driving Competitive Edge in the Breast Biopsy Space

Leading participants in the breast biopsy device space are leveraging strategic investments in research and development to introduce next-generation sampling tools and digital workflow enhancements. Established conglomerates with comprehensive diagnostic portfolios are integrating biopsy platforms with cloud-enabled image management systems, enabling seamless data exchange and remote diagnostic support. These feature-rich offerings are contrasted by specialized device innovators focusing on niche applications such as MRI compatible biopsy needles and rapid on-site evaluation kits.

Mergers and partnerships have become instrumental in expanding technological capabilities, with several key players forming alliances with software providers to embed artificial intelligence modules into guidance consoles. These collaborations emphasize real-time lesion detection and adaptive needle trajectory optimization, setting the stage for reduced procedural variability and improved clinical confidence. At the same time, smaller regional manufacturers are targeting cost-effective device designs tailored to emerging economies, fostering competitive pricing dynamics and expanding access to basic image-guided biopsy services.

Intellectual property portfolios further delineate competitive positioning, as patents covering proprietary needle tip geometries and automation algorithms block new entrants from replicating critical design features. Service contracts and recurring consumables also serve as anchors for customer loyalty, creating recurring revenue streams that support continuous innovation. Collectively, these strategic moves are reshaping the competitive landscape, with innovation velocity and integrated digital solutions emerging as the primary differentiators among industry leaders.

Targeted Strategic Recommendations for Manufacturers Healthcare Providers and Investors to Seize Opportunities and Mitigate Risks in the Breast Biopsy Sector

Manufacturers aiming to solidify their presence should prioritize the development of integrated platforms that combine imaging guidance, automation, and digital reporting functionalities. By aligning product roadmaps with clinician workflows and electronic medical record systems, companies can reduce adoption barriers and demonstrate clear value in procedure efficiency and diagnostic accuracy. Parallel investments in training programs and simulation-based education will further support user proficiency and foster stronger customer relationships.

Healthcare providers are encouraged to evaluate device portfolios holistically, considering not only upfront acquisition costs but also long-term service agreements, consumable consumptions, and potential for integration with existing imaging networks. Engaging with multiple suppliers to pilot emerging technologies can reveal best-fit solutions for specific patient populations and facility requirements. Embracing flexible procurement models, such as pay-per-use or outcome-based contracts, may also mitigate budgetary pressures and accelerate technology adoption.

Investors and industry partners should seek opportunities in regions where screening initiatives are scaling rapidly and regulatory environments are adapting more quickly to digital health solutions. Strategic collaborations with local contract manufacturers and clinical centers can de-risk market entry and facilitate the development of tailored offerings. By focusing on segments with high unmet clinical needs, such as MRI guided biopsy systems for dense breast tissue, stakeholders can position themselves at the forefront of emerging growth corridors.

Comprehensive Multimethod Research Approach Integrating Primary Qualitative Interviews Secondary Data Sources and Rigorous Triangulation Processes

This research employed a multimethod approach combining in-depth qualitative interviews with leading breast imaging specialists, interventional radiologists, and surgical oncologists. These primary insights were complemented by a comprehensive review of peer-reviewed journals, regulatory filings, and professional society guidelines to ensure clinical and scientific rigor. Data points were triangulated across multiple sources to validate procedural trends, device adoption rates, and regional deployment patterns.

Secondary research included an analysis of regulatory databases for device approvals and import-export records to quantify the influence of trade policies. Intellectual property landscapes were mapped using patent registries, while corporate financial statements and investor presentations provided context on strategic priorities and R&D investments. Market intelligence from healthcare conferences and expert panels informed the identification of emerging technologies and ecosystem partnerships.

Throughout the research process, all findings were subjected to peer review by an external advisory board comprising clinicians and industry consultants. This iterative validation step enhanced the reliability of conclusions and ensured that the final report delivers actionable insights grounded in the latest clinical practices and commercial realities.

Synthesis of Critical Findings Underscoring Innovation Adoption Market Shifts Regulatory Developments and Strategic Imperatives for Stakeholders

The breast biopsy device landscape is evolving at a remarkable pace, driven by the convergence of advanced imaging, automated sampling, and digital analysis tools. The shift toward minimally invasive procedures is reducing patient burden while elevating diagnostic confidence. Simultaneously, global trade dynamics and tariff structures are compelling stakeholders to rethink supply chain strategies and regional partnerships.

Segment-driven insights reveal that product innovation must be tailored to distinct clinical workflows, from rapid cytology in aspiration procedures to high-throughput vacuum assisted systems. Regional patterns underscore the necessity of adaptable solutions that address both resource-rich and resource-constrained environments, highlighting the opportunity for scalable device architectures.

Competitive intensity is shaped by a blend of deep-pocketed multinationals integrating AI capabilities and agile niche players customizing cost-effective offerings for localized markets. Future success will hinge on the ability to harmonize technological advancements with streamlined service models, supported by robust training and digital integration. These strategic imperatives will guide industry participants as they navigate an increasingly complex and opportunity-rich clinical milieu.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing adoption of AI-powered imaging guidance in vacuum-assisted breast biopsy devices
  • 5.2. Expansion of ultrasound-guided core needle biopsy solutions for point-of-care breast diagnosis
  • 5.3. Rising demand for minimally invasive stereotactic biopsy systems with 3D imaging integration
  • 5.4. Advancements in biopsy needle design for improved patient comfort and reduced procedure time
  • 5.5. Integration of digital pathology platforms for real-time analysis of breast biopsy samples
  • 5.6. Surge in adoption of portable breast biopsy devices in emerging markets to enhance accessibility
  • 5.7. 3D stereotactic biopsy systems combining robotic precision with lower radiation exposure
  • 5.8. Ergonomically optimized biopsy needles reducing patient discomfort and procedural times
  • 5.9. Mobile breast biopsy units driving early detection initiatives in underserved regions

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Breast Biopsy Device Market, by Product

  • 8.1. Introduction
  • 8.2. Assay Kits
  • 8.3. Biopsy Needles
  • 8.4. Biopsy Tables
  • 8.5. Guidance Systems
  • 8.6. Localization Wires

9. Breast Biopsy Device Market, by Procedure Type

  • 9.1. Introduction
  • 9.2. Core Needle Biopsy
  • 9.3. Fine Needle Aspiration
  • 9.4. Vacuum Assisted Biopsy

10. Breast Biopsy Device Market, by Technique

  • 10.1. Introduction
  • 10.2. MRI Guided
  • 10.3. Stereotactic
  • 10.4. Tomosynthesis Guided
  • 10.5. Ultrasound Guided

11. Breast Biopsy Device Market, by Category

  • 11.1. Introduction
  • 11.2. Automated Biopsy Devices
  • 11.3. Manual Biopsy Devices

12. Breast Biopsy Device Market, by Application

  • 12.1. Introduction
  • 12.2. Benign Lesion Diagnosis
  • 12.3. Malignant Lesion Diagnosis

13. Breast Biopsy Device Market, by End User

  • 13.1. Introduction
  • 13.2. Ambulatory Surgery Centers
  • 13.3. Diagnostic Imaging Centers
  • 13.4. Hospitals

14. Breast Biopsy Device Market, by Distribution Channel

  • 14.1. Introduction
  • 14.2. Offline Sales
  • 14.3. Online Sales

15. Americas Breast Biopsy Device Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Breast Biopsy Device Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Breast Biopsy Device Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Advin Health Care
    • 18.3.2. Argon Medical Devices, Inc.
    • 18.3.3. Becton, Dickinson and Company
    • 18.3.4. Cook Group Incorporated
    • 18.3.5. Danaher Corporation
    • 18.3.6. FUJIFILM Corporation
    • 18.3.7. General Electric Company
    • 18.3.8. Halma plc
    • 18.3.9. Hologic, Inc
    • 18.3.10. INRAD Inc.
    • 18.3.11. Medline Industries, LP
    • 18.3.12. Medtronic PLC
    • 18.3.13. Merit Medical Systems, Inc.
    • 18.3.14. Ningbo Xinwell Medical Technology Co., LTD.
    • 18.3.15. PAJUNK GmbH
    • 18.3.16. Planmeca Oy
    • 18.3.17. Point Blank Medical
    • 18.3.18. Siemens AG
    • 18.3.19. SNVL Varay Laborix
    • 18.3.20. STERYLAB S.r.l.
    • 18.3.21. Suretech Medical Inc.
    • 18.3.22. Thermo Fisher Scientific Inc.
    • 18.3.23. Trivitron Healthcare
    • 18.3.24. Vector Medical, Inc.
    • 18.3.25. Zamar Care

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. BREAST BIOPSY DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. BREAST BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BREAST BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. BREAST BIOPSY DEVICE MARKET: RESEARCHAI
  • FIGURE 30. BREAST BIOPSY DEVICE MARKET: RESEARCHSTATISTICS
  • FIGURE 31. BREAST BIOPSY DEVICE MARKET: RESEARCHCONTACTS
  • FIGURE 32. BREAST BIOPSY DEVICE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. BREAST BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY VACUUM ASSISTED BIOPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY STEREOTACTIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY TOMOSYNTHESIS GUIDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AUTOMATED BIOPSY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MANUAL BIOPSY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY BENIGN LESION DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY MALIGNANT LESION DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY OFFLINE SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST BIOPSY DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES BREAST BIOPSY DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 103. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 104. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 105. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 110. CANADA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 116. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 117. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 118. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 119. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 123. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. MEXICO BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 127. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 130. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 131. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 132. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 133. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 135. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 137. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. BRAZIL BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 139. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 141. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 144. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 145. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 146. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 147. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 152. ARGENTINA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED KINGDOM BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 183. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 184. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 185. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 188. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 189. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 190. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 191. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 195. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. GERMANY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 197. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 198. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 199. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 202. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 203. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 204. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 205. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. FRANCE BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 211. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 213. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 216. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 217. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 218. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 219. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 224. RUSSIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 225. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 226. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 227. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 230. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 231. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 233. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 237. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. ITALY BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 239. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 241. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 243. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 244. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 245. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 246. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 247. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 249. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 251. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. SPAIN BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. SAUDI ARABIA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 286. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 288. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. SOUTH AFRICA BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 295. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 296. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 297. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 300. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 301. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 302. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 303. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 305. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 307. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 308. DENMARK BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 309. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 310. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 311. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 314. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 316. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 317. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 322. NETHERLANDS BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 323. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 324. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 325. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 328. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
  • TABLE 329. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 330. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 331. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 333. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 335. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. QATAR BREAST BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 337. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 338. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 339. FINLAND BREAST BIOPSY DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. FINL